Elliot Tapper: Continuing Anticoagulation Improves PVT Outcomes During Banding
Elliot Tapper, Academic Chief of Hepatology and Andrews Family Research Professor at the University of Michigan, shared a post on LinkedIn about a recent article by Yingying He et al. published in Therapeutic Advances in Gastroenterology, adding:
“Thing we do for no reason?
A trial assessed continuing vs stopping anticoagulation in patients with portal vein thrombosis undergoing banding
AC: enoxaparin
Mixed pop of acute bleeding and secondary prophylaxis
Continuing AC better.”
Title: Continuous versus intermittent anticoagulation during endoscopic treatment of esophageal varices in cirrhosis: a randomized controlled trial
Authors: Yingying He, Zhihong Wang, Jiayi Zhang, Qianqian Zhang, Yaxian Kuai, Yuchuan Bai, Xuecan Mei, Derun Kong

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C